Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Chemomab Therapeutics Ltd. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 12 | 15 | +3 |
| Shares | 3.09M | 3.24M | +155.8K (+5.0%) |
| Value | $58.7M | $35.9M | −$22.8M (−38.8%) |
New holders (7)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 180,523 | $2.00M | 0.00% |
| Advisor Group Holdings, Inc. | 54,821 | $608.0K | 0.00% |
| State Street Corp | 30,504 | $338.0K | 0.00% |
| Geode Capital Management, LLC | 13,738 | $152.0K | 0.00% |
| Apollon Wealth Management, LLC | 12,000 | $133.0K | 0.02% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 3,097 | $34.0K | 0.03% |
| Tower Research Capital LLC (TRC) | 49 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Marshall Wace, LLP | 63,554 | $1.21M |
| Marshall Wace North America L.P. | 44,035 | $837.0K |
| Virtu Financial LLC | 13,180 | $251.0K |
| JPMorgan Chase & Co | 51 | $1.00K |